Study details
Enrolling now
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
M.D. Anderson Cancer Center
NCT IDNCT05454488ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
30
Study length
about 3.5 years
Ages
18+
Sex
Male only
Locations
1 site in TX
What this study is about
Researchers are testing if using cryotherapy to treat only the part of the prostate known to contain cancer is effective in controlling prostate cancer. The trial will measure how well the treatment works by looking at whether the cancer returns in the treated area and how it affects quality of life.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Quality-of-life Questionnaires
- 2.Standard of Care
- 3.Take Focal Cryoablation
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Quality-of-life Questionnaires
Body systems
Oncology